Successful overcoming of apocrine cancer requires the integration of advanced diagnostic systems and personalized treatment strategies tailored to the biological profile of the specific tumour. Israeli oncology is at the forefront due to the systematic implementation of molecular-genetic analysis, which allows oncologists to accurately identify the vulnerabilities of the neoplasm. Specialists at the Ihilov clinic, possessing immense clinical experience in combating rare pathologies, apply innovative protocols that have undergone rigorous international certification.
The high-tech infrastructure of the center, combined with the expert level of medical personnel, guarantees not only the accuracy of treatment manipulations but also a reduction in the time to achieve remission. Clear coordination of each stage of therapy, along with impeccable service, provides patients with maximum confidence and comfort throughout their recovery journey.
About the disease
Apocrine cancer is a rare malignant tumour that develops from apocrine sweat glands, most often in the armpits or groin area.
The disease arises due to genetic mutations in gland cells, the exact causes of which are not fully established, although a connection with prolonged exposure to carcinogenic factors is observed.
The tumour manifests as painful lumps, skin ulcerations, foul-smelling discharges, and a tendency to metastasize to lymph nodes. Progression of the process leads to restricted mobility, constant discomfort, and a significant decrease in quality of life.
Treatment methods for apocrine cancer
At the Ihilov clinic, the choice of therapeutic strategy is based on the results of molecular-genetic profiling of the tumour, the stage of the disease, and the overall condition of the patient.
Surgical removal of the tumour
Surgical intervention is applied in the early stages of the disease when the tumour is confined to the primary focus. Surgeons use intraoperative navigation and fluorescent imaging technologies to determine the exact boundaries of the malignant tissue. Modern microsurgical instruments allow for the maximum preservation of healthy structures while completely removing pathological cells. After resection, immediate histological examination of the resection margins is conducted, ensuring the radicality of the operation and reducing the risk of recurrence.
Radiation therapy
Radiotherapy is prescribed after the surgical stage to destroy residual malignant cells or as a standalone method when surgery is not possible. The use of IMRT and IGRT systems ensures precise targeting of radiation to the tumour area with minimal impact on surrounding tissues. The fractionation of the dose is calculated individually, taking into account the sensitivity of the tumour and the patient's tolerance to therapy. Stereotactic radiosurgery is used to treat solitary metastases, allowing for local control of the disease over several sessions.
Chemotherapy
In cases of widespread disease with lymph node involvement or distant metastases, systemic chemotherapy is applied. Protocols include combinations of drugs from the groups of alkylating agents, antimetabolites, and antitumor antibiotics, selected according to the molecular profile of the neoplasm. Modern regimens provide for supportive therapy to prevent side effects, significantly improving treatment tolerance. Monitoring of effectiveness is carried out through regular imaging studies with the possibility of protocol adjustment in case of insufficient tumour response.
Targeted therapy
Molecular-targeted treatment is prescribed to patients with identified specific genetic mutations in tumour cells. Drugs from the group of tyrosine kinase inhibitors or monoclonal antibodies block the signaling pathways necessary for the growth and division of cancer cells. This approach demonstrates high efficacy with lower toxicity compared to traditional chemotherapy. Regular monitoring of markers allows for assessing disease dynamics and timely detection of the development of resistance to therapy.
Immunotherapy
Immuno-oncological drugs activate the body's own immune system to recognize and destroy cancer cells. Immune checkpoint inhibitors are used for tumours with high mutational burden or expression of specific biomarkers. This method is especially effective in combination with other types of therapy, enhancing the overall antitumor effect. The duration of response to immunotherapy often exceeds that of standard treatment regimens, which is important for long-term prognosis.
Reconstructive surgery
After radical removal of extensive tumours, there arises a need to restore the anatomical structures and functions of the affected area. Plastic surgeons use tissue flap transplantation methods and microsurgical techniques to achieve optimal cosmetic results. Reconstruction can be performed either simultaneously with the main operation or delayed after the completion of adjuvant therapy. Restorative procedures significantly improve the quality of life for patients and their psychological adaptation after treatment.
- Radiation therapy
- Chemotherapy
- Oncological surgeries
Diagnostic methods for the disease
Accurate diagnosis of apocrine cancer determines the success of subsequent treatment and allows for the identification of all disease foci to develop an optimal therapeutic strategy. The Ihilov clinic uses high-precision expert-class equipment, and all diagnostic procedures are planned in advance and performed within the shortest possible time, usually within three working days.
First day
Upon arrival at the clinic, the patient meets with the treating oncologist, who collects a detailed medical history, reviews existing medical documentation, and results of previous studies. The doctor conducts a thorough physical examination, palpation of the affected area and regional lymph nodes, and assesses the overall condition of the patient. Based on the obtained data, the specialist develops an individual plan for diagnostic studies that will help visualize the complete picture of the condition and determine the extent of the tumour process.
Second day
The patient undergoes a comprehensive set of diagnostic procedures according to the developed plan.
- Comprehensive biochemical blood analysis
- Complete blood count with leukocyte formula
- Oncomarker studies
- Coagulogram
- Tumour biopsy with histological examination
- Immunohistochemical analysis of the biopsy
- Molecular-genetic testing of the tumour tissue
- CT of the affected area with contrast
- Whole-body PET-CT to detect metastases
- MRI for detailed visualization of soft tissues
- Ultrasound of regional lymph nodes
- X-ray of the chest organs
Third day
The treating physician gathers a consultation with oncologists, surgeons, and radiologists for a comprehensive analysis of all research results. Collegial discussion of the clinical case, taking into account international protocols and the individual characteristics of the patient, allows for the development of the most relevant treatment plan. Upon completion of the consultation, the patient receives detailed recommendations for all stages of the upcoming therapy, including timelines and expected outcomes.
- Computed tomography
- Magnetic Resonance Imaging (MRI)
- Diagnosis — PET CT
- Ultrasound
- Biopsy and histological studies
- Blood biochemistry
- Chest X-ray
How much does treatment cost in Israel
The cost of treating apocrine cancer is calculated individually and depends on the stage of the disease, the volume of necessary diagnostic procedures, selected treatment methods, and the duration of stay in the clinic.
To obtain an accurate cost estimate for a specific case, it is necessary to contact a consultant at the phone number provided on the website. The consultant will provide a preliminary treatment estimate, assist in organizing all stages of the trip, and answer questions regarding medical and organizational aspects.
Advantages of treatment in Israel
- Oncologists with many years of experience in rare forms of malignant neoplasms
- Use of molecular-genetic profiling of tumours for personalized therapy
- Access to innovative treatment protocols and participation in international clinical trials
- High-precision diagnostic equipment of expert class and expedited examination timelines
- Comfortable accommodation conditions with full medical support at all stages
Even before arriving at the Israeli clinic, the patient can request an online consultation with the necessary specialist to obtain an expert opinion on their case. As a result of the remote consultation, recommendations for further treatment tactics, answers to questions of interest, and information about available modern technologies for treating apocrine cancer can be obtained.